GTG hails successful year despite mixed results

By Dylan Bushell-Embling
Wednesday, 03 September, 2008


Genetic Technologies [ASX: GTG] has reported what company representatives believe to be positive financial year results, even though it experienced a consolidated loss of over $5 million.

Consolidated loss after tax for FY08 was up 25 per cent to $5.4 million, despite a five per cent increase in revenue to $15.7 million and positive net cash flows from operations.

As a result of this loss, the company has no plans to pay share dividends, and the company's consolidated net tangible assets have decreased from four to 3.83 cents per share.

According to GTG, these losses resulted from amortisation of patents, impairment losses, depreciation of plant and equipment, foreign exchange losses and share-based payment expenses.

Over the period, GTG also acquired the Frozen Puppies Dot Com business and a 15 per cent stake in a mining venture.

The company also continued to develop products which are coming closer to commercialisation, it said.

Related Articles

Mini lung organoids could help test new treatments

Scientists have developed a simple method for automated the manufacturing of lung organoids...

Clogged 'drains' in the brain an early sign of Alzheimer’s

'Drains' in the brain, responsible for clearing toxic waste in the organ, tend to get...

World's oldest known RNA extracted from woolly mammoth

The RNA sequences are understood to be the oldest ever recovered, coming from mammoth tissue...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd